Hidenao Noritake

Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study

Hideki Fujii, Michihiro Iwaki, Hideki Hayashi et al. · Clinical Gastroenterology and Hepatology · 2022 · 102 citations

Metabolic Syndrome, Metabolic Associated Steatohepatitis, Hepatology +11

Enhanced Hepatic Nrf2 Activation After Ursodeoxycholic Acid Treatment in Patients with Primary Biliary Cirrhosis

Kazuhito Kawata, Yoshimasa Kobayashi, Kenichi Souda et al. · Antioxidants and Redox Signaling · 2010 · 55 citations · Full text

Lipid Peroxidation, Gastroenterology, Pathology +21

Simvastatin inhibits hepatic stellate cells activation by regulating the ferroptosis signaling pathway

Kensuke Kitsugi, Hidenao Noritake, Moe Matsumoto et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2023 · 43 citations

Inflammation, Signal Transduction, Hepatology +11

Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1b

Takeshi Chida, Kazuhito Kawata, Kazuyoshi Ohta et al. · Gut and Liver · 2017 · 36 citations · Full text

An Inhibitor of Arginine‐Glycine‐Aspartate‐Binding Integrins Reverses Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis

Barbara Ulmasov, Hidenao Noritake, Peter Carmichael et al. · Hepatology Communications · 2018 · 35 citations · Full text